Structure, heterogeneity and developability assessment of therapeutic antibodies
Open accessThe DOI matches its Crossref record; 322 of the 322 references it cites were found in a registry or an index.
Abstract
Increasing attention has been paid to developability assessment with the understanding that thorough evaluation of monoclonal antibody lead candidates at an early stage can avoid delays during late-stage development. The concept of developability is based on the knowledge gained from the successful development of approximately 80 marketed antibody and Fc-fusion protein drug products and from the lessons learned from many failed development programs over the last three decades. Here, we reviewed antibody quality attributes that are critical to development and traditional and state-of-the-art analytical methods to monitor those attributes. Based on our collective experiences, a practical workflow is proposed as a best practice for developability assessment including in silico evaluation, extended characterization and forced degradation using appropriate analytical methods that allow characterization with limited material consumption and fast turnaround time.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–322 of 322
Banks, D. D., Gadgil, H. S., Pipes, G. D., Bondarenko, P. V., Hobbs, V., Scavezze, J. L., Kim, J., Jiang, X., Mukku, V. R., & Dillon, T. M. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21014 · Cited by 87
Immunogenicity screening in protein drug development
Van Walle, I., Gansemans, Y., Parren, P. W., Stas, P., & Lasters, I. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.3.405 · Cited by 87
Chaudhri, A., Zarraga, I. E., Yadav, S., Patapoff, T. W., Shire, S. J., & Voth, G. A. (2013) · The Journal of Physical Chemistry B · doi:10.1021/jp3108396 · Cited by 87
Sharma, D. K., Oma, P., Pollo, M. J., & Sukumar, M. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22046 · Cited by 86
Schröter, C., Günther, R., Rhiel, L., Becker, S., Toleikis, L., Doerner, A., Becker, J., Schönemann, A., Nasu, D., Neuteboom, B., et al. (2015) · mAbs · doi:10.4161/19420862.2014.985993 · Cited by 86
Analysis of isoaspartate in a recombinant monoclonal antibody and its charge isoforms
Zhang, W., & Czupryn, M. J. (2002) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(02)00479-x · Cited by 86
Franey, H., Brych, S. R., Kolvenbach, C. G., & Rajan, R. S. (2010) · Protein Science · doi:10.1002/pro.434 · Cited by 86
Antes, B., Amon, S., Rizzi, A. M., Wiederkum, S., Kainer, M., Szolar, O. H. J., Fido, M., Kircheis, R., & Nechansky, A. (2007) · Journal of Chromatography B · doi:10.1016/j.jchromb.2007.01.024 · Cited by 86
Comparison of LC and LC/MS methods for quantifying N -glycosylation in recombinant IgGs
Sinha, S., Pipes, G. D., Topp, E. M., Bondarenko, P. V., Treuheit, M. J., & Gadgil, H. S. (2008) · Journal of the American Society for Mass Spectrometry · doi:10.1016/j.jasms.2008.07.004 · Cited by 85
Leibiger, H., Wüstner, D., Stigler, R.-D., & Marx, U. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3380529 · Cited by 84
Wang, L., Amphlett, G. W., Lambert, J. M., Blättler, W. A., & Zhang, W. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-5267-7 · Cited by 83
Bumbaca Yadav, D., Sharma, V. K., Boswell, C. A., Hotzel, I., Tesar, D., Shang, Y., Ying, Y., Fischer, S. K., Grogan, J. L., Chiang, E. Y., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.692434 · Cited by 82
Maeda, E., Kita, S., Kinoshita, M., Urakami, K., Hayakawa, T., & Kakehi, K. (2012) · Analytical Chemistry · doi:10.1021/ac300234a · Cited by 82
Detecting low level sequence variants in recombinant monoclonal antibodies
Yang, Y., Strahan, A., Li, C., Shen, A. Y., Liu, H., Ouyang, J., Katta, V., Francissen, K., & Zhang, B. (2010) · mAbs · doi:10.4161/mabs.2.3.11718 · Cited by 81
Self-citationZhang, T., Bourret, J., & Cano, T. (2011) · Journal of Chromatography A · doi:10.1016/j.chroma.2011.05.061 · Cited by 81
Evidence for Trisulfide Bonds in a Recombinant Variant of a Human IgG2 Monoclonal Antibody
Pristatsky, P., Cohen, S. L., Krantz, D., Acevedo, J., Ionescu, R. M., & Vlasak, J. (2009) · Analytical Chemistry · doi:10.1021/ac9006254 · Cited by 81
Yang, J. H., Wang, S., Liu, J., & Raghani, A. R. (2007) · Journal of Chromatography A · doi:10.1016/j.chroma.2007.01.140 · Cited by 81
Yu, L., Vizel, A., Huff, M. B., Young, M. W., Remmele, R. L., & He, B. (2006) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2006.05.008 · Cited by 80
Wang, X., Singh, S. K., & Kumar, S. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0143-5 · Cited by 79
Chemical and Physical Stability of Chimeric L6, a Mouse−Human Monoclonal Antibody
Paborji, M., Pochopin, N. L., Coppola, W. P., & Bogardus, J. B. (1994) · Pharmaceutical Research · doi:10.1023/a:1018948901599 · Cited by 79
Co, M. S., Scheinberg, D. A., Avdalovic, N. M., McGraw, K., Vásquez, M., Caron, P. C., & Queen, C. (1993) · Molecular Immunology · doi:10.1016/0161-5890(93)90097-u · Cited by 79
Predictive tools for stabilization of therapeutic proteins
Voynov, V., Chennamsetty, N., Kayser, V., Helk, B., & Trout, B. L. (2009) · mAbs · doi:10.4161/mabs.1.6.9773 · Cited by 79
Harris, R. J., Murnane, A. A., Utter, S. L., Wagner, K. L., Cox, E. T., Polastri, G., Helder, J. C., & Sliwkowski, M. B. (1993) · Nature Biotechnology · doi:10.1038/nbt1193-1293 · Cited by 78
Rapid Analysis of Antibody Self-Association in Complex Mixtures Using Immunogold Conjugates
Sule, S. V., Dickinson, C. D., Lu, J., Chow, C.-K., & Tessier, P. M. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300524x · Cited by 78
Yu, X. C., Borisov, O. V., Alvarez, M., Michels, D. A., Wang, Y. J., & Ling, V. (2009) · Analytical Chemistry · doi:10.1021/ac901541h · Cited by 77
Majumdar, R., Esfandiary, R., Bishop, S. M., Samra, H. S., Middaugh, C. R., Volkin, D. B., & Weis, D. D. (2014) · mAbs · doi:10.4161/19420862.2014.985494 · Cited by 76
A novel screening method to assess developability of antibody-like molecules
Kohli, N., Jain, N., Geddie, M. L., Razlog, M., Xu, L., & Lugovskoy, A. A. (2015) · mAbs · doi:10.1080/19420862.2015.1048410 · Cited by 74
Singh, S. N., Yadav, S., Shire, S. J., & Kalonia, D. S. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1352-0 · Cited by 74
HIC resolution of an IgG1 with an oxidized Trp in a complementarity determining region
Boyd, D., Kaschak, T., & Yan, B. (2011) · Journal of Chromatography B · doi:10.1016/j.jchromb.2011.03.006 · Cited by 74
Kalonia, C. K., Toprani, V. M., Toth, R., Wahome, N., Gabel, I., Middaugh, C. R., & Volkin, D. B. (2016) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.6b03878 · Cited by 74
Separation of oxidized variants of a monoclonal antibody by anion-exchange
Teshima, G. M., Li, M., Danishmand, R., Obi, C., To, R., Huang, C. B., Kung, J., Lahidji, V., Freeberg, J. K., Thorner, L., et al. (2010) · Journal of Chromatography A · doi:10.1016/j.chroma.2010.10.107 · Cited by 73
Ouellette, D., Alessandri, L., Chin, A. T., Grinnell, C. M., Tarcsa, E., Radziejewski, C. H., & Correia, I. (2009) · Analytical Biochemistry · doi:10.1016/j.ab.2009.09.027 · Cited by 73
Chumsae, C. M., Gifford, K., Lian, W., Liu, H., Radziejewski, C. H., & Zhou, Z. S. (2013) · Analytical Chemistry · doi:10.1021/ac402384y · Cited by 73
Self-citationZhang, T., Zhang, J., Hewitt, D., Tran, B., Gao, X., Qiu, Z. J., Tejada, M. L., Gazzano, H., & Kao, Y. (2012) · Analytical Chemistry · doi:10.1021/ac301426h · Cited by 72
He, Y., Lacher, N. A., Hou, W., Wang, Q., Isele, C., Starkey, J., & Ruesch, M. (2010) · Analytical Chemistry · doi:10.1021/ac9028856 · Cited by 72
Buchanan, A. G., Clementel, V. A., Woods, R., Harn, N. R., Bowen, M. A., Mo, W., Popovic, B., Bishop, S. M., Dall’Acqua, W. F., Minter, R., et al. (2013) · mAbs · doi:10.4161/mabs.23392 · Cited by 71
van den Bremer, E. T. J., Beurskens, F. J. M., Voorhorst, M., Engelberts, P. J., de Jong, R. N., van der Boom, B. G., Cook, E. M., Lindorfer, M. A., Taylor, R. P., van Berkel, P. H. C., et al. (2015) · mAbs · doi:10.1080/19420862.2015.1046665 · Cited by 70
Wen, D., Vecchi, M. M., Gu, S., Su, L., Dolníková, J., Huang, Y., Foley, S. F., Garber, E. A., Pederson, N. E., & Meier, W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.059360 · Cited by 70
Tessier, P. M., Sandler, S. I., & Lenhoff, A. M. (2004) · Protein Science · doi:10.1110/ps.03419204 · Cited by 69
Bye, J. W., Platts, L., & Falconer, R. J. (2014) · Biotechnology Letters · doi:10.1007/s10529-013-1445-6 · Cited by 67
Guo, D., Gao, A. E., Michels, D. A., Feeney, L., Eng, M., Chan, B., Laird, M. W., Zhang, B., Yu, X. C., Joly, J. C., et al. (2010) · Biotechnology and Bioengineering · doi:10.1002/bit.22780 · Cited by 67
Kumar, V., Sharma, V. K., & Kalonia, D. S. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.08.037 · Cited by 67
Boosting antibody developability through rational sequence optimization
Seeliger, D., Schulz, P., Litzenburger, T., Spitz, J., Hoerer, S., Blech, M., Enenkel, B., Studts, J. M., Garidel, P., & Karow, A. R. (2015) · mAbs · doi:10.1080/19420862.2015.1017695 · Cited by 66
Datta‐Mannan, A., Chow, C.-K., Dickinson, C. D., Driver, D. A., Lu, J., Witcher, D. R., & Wroblewski, V. J. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.045864 · Cited by 66
Yang, R., Jain, T., Lynaugh, H., Nobrega, R. P., Lu, X., Boland, T., Burnina, I., Sun, T., Caffry, I., Brown, M., et al. (2017) · mAbs · doi:10.1080/19420862.2017.1290753 · Cited by 66
Self-citationGiorgetti, J., D’Atri, V., Canonge, J., Lechner, A., Guillarme, D., Colas, O., Wagner-Rousset, E., Beck, A., Leize-Wagner, E., & François, Y.-N. (2018) · Talanta · doi:10.1016/j.talanta.2017.09.083 · Cited by 65
Self-citationGeng, S. B., Cheung, J. K., Narasimhan, C. N., Shameem, M., & Tessier, P. M. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24130 · Cited by 65
Self-citationCharacterization of Antibody Charge Heterogeneity Resolved by Preparative Immobilized pH Gradients
Meert, C., Brady, L. J., Guo, A., & Balland, A. (2010) · Analytical Chemistry · doi:10.1021/ac902408r · Cited by 65
Valliere‐Douglass, J. F., Jones, L., Shpektor, D., Kodama, P., Wallace, A. M. R., Balland, A., Bailey, R. W., & Zhang, Y. (2008) · Analytical Chemistry · doi:10.1021/ac702245c · Cited by 64
Kayser, V., Chennamsetty, N., Voynov, V., Helk, B., & Trout, B. L. (2011) · mAbs · doi:10.4161/mabs.3.4.15677 · Cited by 64
Control of misincorporation of serine for asparagine during antibody production using CHO cells
Khetan, A., Huang, Y., Dolníková, J., Pederson, N. E., Wen, D., Yusuf‐Makagiansar, H., Chen, P. L., & Ryll, T. (2010) · Biotechnology and Bioengineering · doi:10.1002/bit.22771 · Cited by 64
Estep, P., Caffry, I., Yu, Y., Sun, T., Cao, Y., Lynaugh, H., Jain, T., Vásquez, M., Tessier, P. M., & Xu, Y. (2015) · mAbs · doi:10.1080/19420862.2015.1016694 · Cited by 63
Self-citationNarasimhan, C. N., Mach, H., & Shameem, M. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.68 · Cited by 63
Sreedhara, A., Cordoba, A. J., Zhu, Q., Kwong, J., & Liu, J. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0534-2 · Cited by 63
Gandhi, S. P., Ren, D., Xiao, G., Bondarenko, P. V., Sloey, C. J., Speed, M. A., & Krishnan, S. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0536-0 · Cited by 63
Analysis of recombinant monoclonal antibodies by capillary zone electrophoresis
la Garza, C. E. E., Perdomo‐Abúndez, F. C., Padilla‐Calderón, J., Uribe‐Wiechers, J. M., Pérez, N. O., Flores-Ortiz, L. F., & Medina‐Rivero, E. (2013) · Electrophoresis · doi:10.1002/elps.201200575 · Cited by 61
High-Throughput Analysis of Concentration-Dependent Antibody Self-Association
Sule, S. V., Sukumar, M., Weiss, W. F., Marcelino, A. M. C., Sample, T., & Tessier, P. M. (2011) · Biophysical Journal · doi:10.1016/j.bpj.2011.08.036 · Cited by 61
Alford, J. R., Kendrick, B. S., Carpenter, J. F., & Randolph, T. W. (2008) · Analytical Biochemistry · doi:10.1016/j.ab.2008.03.032 · Cited by 60
Lavoisier, A., & Schlaeppi, J.-M. (2014) · mAbs · doi:10.4161/19420862.2014.985544 · Cited by 59
Computational Methods to Predict Therapeutic Protein Aggregation
Buck, P. M., Kumar, S., Wang, X., Agrawal, N. J., Trout, B. L., & Singh, S. K. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-61779-921-1_26 · Cited by 59
Neill, A., Nowak, C., Patel, R., Ponniah, G., Gonzalez, N., Miano, D., & Liu, H. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b01452 · Cited by 58
Self-citationRelevant shaking stress conditions for antibody preformulation development
Eppler, A., Weigandt, M., Hanefeld, A., & Bunjes, H. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.11.005 · Cited by 57
Salting-in characteristics of globular proteins
Maurer, R. W., Sandler, S. I., & Lenhoff, A. M. (2011) · Biophysical Chemistry · doi:10.1016/j.bpc.2011.02.002 · Cited by 55
Fang, J. S., Richardson, J., Du, Z., & Zhang, Z. (2016) · Biochemistry · doi:10.1021/acs.biochem.5b01323 · Cited by 55
Kleemann, G. R., Beierle, J., Nichols, A. C., Dillon, T. M., Pipes, G. D., & Bondarenko, P. V. (2008) · Analytical Chemistry · doi:10.1021/ac701629v · Cited by 54
Zhang, Y. T., Hu, J. J., Pace, A. L., Wong, R. L., Wang, Y. J., & Kao, Y. (2014) · Journal of Chromatography B · doi:10.1016/j.jchromb.2014.06.018 · Cited by 52
Huh, J. H., White, A. J., Brych, S. R., Franey, H., & Matsumura, M. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23505 · Cited by 52
Dashivets, T., Stracke, J. O., Dengl, S., Knaupp, A., Pollmann, J., Büchner, J., & Schlothauer, T. (2016) · mAbs · doi:10.1080/19420862.2016.1231277 · Cited by 52
Nishi, H., Miyajima, M., Wakiyama, N., Kubota, K., Hasegawa, J., Uchiyama, S., & Fukui, K. (2011) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2011.06.017 · Cited by 51
High throughput detection of antibody self-interaction by bio-layer interferometry
Sun, T., Reid, F., Liu, Y., Cao, Y., Estep, P., Nauman, C., & Xu, Y. (2013) · mAbs · doi:10.4161/mabs.26186 · Cited by 51
Self-citationLiu, H., Gaza‐Bulseco, G., & Zhou, L. (2008) · Journal of the American Society for Mass Spectrometry · doi:10.1016/j.jasms.2008.11.011 · Cited by 51
Self-citationAssessment of antibody fragmentation by reversed-phase liquid chromatography and mass spectrometry
Liu, H., Gaza‐Bulseco, G., & Lundell, E. O. (2008) · Journal of Chromatography B · doi:10.1016/j.jchromb.2008.10.015 · Cited by 51
Self-citationShi, Y., Li, Z., Qiao, Y.-B., & Lin, J. H. (2012) · Journal of Chromatography B · doi:10.1016/j.jchromb.2012.08.022 · Cited by 51
Target-independent variable region mediated effects on antibody clearance can be FcRn independent
Kelly, R. L., Yu, Y., Sun, T., Caffry, I., Lynaugh, H., Brown, M., Jain, T., Xu, Y., & Wittrup, K. D. (2016) · mAbs · doi:10.1080/19420862.2016.1208330 · Cited by 51
Self-citationLi, L., Kantor, A., & Warne, N. W. (2013) · Protein Science · doi:10.1002/pro.2289 · Cited by 50
IgG1 Thioether Bond Formation in Vivo
Zhang, Q., Schenauer, M. R., McCarter, J. D., & Flynn, G. C. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.468397 · Cited by 48
Ponniah, G., Kita, A., Nowak, C., Neill, A., Kori, Y., Rajendran, S., & Liu, H. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b02385 · Cited by 47
Self-citationPonniah, G., Nowak, C., Neill, A., & Liu, H. (2016) · Analytical Biochemistry · doi:10.1016/j.ab.2016.12.017 · Cited by 47
Self-citationPhillips, J. J., Buchanan, A. G., Andrews, J. L., Chodorge, M., Sridharan, S., Mitchell, L., Burmeister, N., Kippen, A. D., Vaughan, T. J., Higazi, D. R., et al. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.6b04158 · Cited by 47
Quantitative analysis of glycation and its impact on antigen binding
Mo, J., Jin, R., Yan, Q., Sokolowska, I., Lewis, M. J., & Hu, P. (2018) · mAbs · doi:10.1080/19420862.2018.1438796 · Cited by 47
Rational Design of Biobetters with Enhanced Stability
Courtois, F., Schneider, C. P., Agrawal, N. J., & Trout, B. L. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24520 · Cited by 46
Huang, H. Z., Nichols, A. C., & Liu, D. (2009) · Analytical Chemistry · doi:10.1021/ac802708s · Cited by 46
Self-citationDevelopment of a fast workflow to screen the charge variants of therapeutic antibodies
Wagner‐Rousset, E., Fekete, S., Laura, M.-C., Colas, O., Corvaïa, N., Cianférani, S., Guillarme, D., & Beck, A. (2017) · Journal of Chromatography A · doi:10.1016/j.chroma.2017.02.065 · Cited by 45
Self-citationPharmacokinetic de-risking tools for selection of monoclonal antibody lead candidates
Dostalek, M., Prueksaritanont, T., & Kelley, R. F. (2017) · mAbs · doi:10.1080/19420862.2017.1323160 · Cited by 45
A novel in vitro assay to predict neonatal Fc receptor-mediated human IgG half-life
Souders, C. A., Nelson, S. C., Wang, Y., Crowley, A. R., Klempner, M. S., & Thomas, W. (2015) · mAbs · doi:10.1080/19420862.2015.1054585 · Cited by 44
Xiang, T., Chumsae, C. M., & Liu, H. (2009) · Analytical Chemistry · doi:10.1021/ac901311y · Cited by 44
Self-citationBaek, Y., Singh, N., Arunkumar, A., Borys, M., Li, Z. J., & Zydney, A. L. (2017) · Biotechnology and Bioengineering · doi:10.1002/bit.26326 · Cited by 44
Tsubaki, M., Terashima, I., Kamata, K., & Koga, A. (2012) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2012.09.016 · Cited by 43
Falck, D., Jansen, B. C., Plomp, R., Reusch, D., Haberger, M., & Wuhrer, M. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00573 · Cited by 43
Intermolecular interactions in highly concentrated formulations of recombinant therapeutic proteins
Baek, Y., & Zydney, A. L. (2017) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.12.016 · Cited by 41
Low Level Sequence Variant Analysis of Recombinant Proteins: An Optimized Approach
Zeck, A., Regula, J. T., Larraillet, V., Mautz, B., Popp, O., Göpfert, U., Wiegeshoff, F., Vollertsen, U. E. E., Gorr, I. H., Koll, H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040328 · Cited by 40
DSF Method Optimization and Its Application in Predicting Protein Thermal Aggregation Kinetics
Shi, S., Semple, A., Cheung, J. K., & Shameem, M. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23633 · Cited by 39
Self-citationAlmagro, J. C., Raghunathan, G., Beil, E. J., Janecki, D. J., Chen, Q., Dinh, T., LaCombe, A., Connor, J., Ware, M., Kim, P. H., et al. (2012) · Journal of Molecular Recognition · doi:10.1002/jmr.1168 · Cited by 38
Gahoual, R., Beck, A., François, Y., & Leize‐Wagner, E. (2016) · Journal of Mass Spectrometry · doi:10.1002/jms.3735 · Cited by 38
Self-citationKamerzell, T. J., Kanai, S., Liu, J., Shire, S. J., & Wang, Y. J. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp9001548 · Cited by 37
From osmotic second virial coefficient ( B 22 ) to phase behavior of a monoclonal antibody
Rakel, N., Bauer, K. C., Galm, L., & Hubbuch, J. J. (2015) · Biotechnology Progress · doi:10.1002/btpr.2065 · Cited by 37
Recombinant Antibody Color Resulting from Advanced Glycation End Product Modifications
Butko, M. T., Pallat, H., Cordoba, A. J., & Yu, X. C. (2014) · Analytical Chemistry · doi:10.1021/ac5024099 · Cited by 36
Toprani, V. M., Joshi, S. B., Kueltzo, L. A., Schwartz, R. M., Middaugh, C. R., & Volkin, D. B. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.05.021 · Cited by 35
Yang, Y., Velayudhan, A., Thornhill, N. F., & Farid, S. S. (2017) · Biotechnology and Bioengineering · doi:10.1002/bit.26329 · Cited by 35
Onitsuka, M., Kawaguchi, A., Asano, R., Kumagai, I., Honda, K., Ohtake, H., & Ōmasa, T. (2013) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2013.11.001 · Cited by 33
Chaperone proteins as single component reagents to assess antibody nonspecificity
Kelly, R. L., Geoghegan, J. C., Feldman, J. E., Jain, T. S., Kauke, M. J., Le, D., Zhao, J., & Wittrup, K. D. (2017) · mAbs · doi:10.1080/19420862.2017.1356529 · Cited by 33
Characterization of Cysteinylation and Trisulfide Bonds in a Recombinant Monoclonal Antibody
Kita, A., Ponniah, G., Nowak, C., & Liu, H. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b00822 · Cited by 32
Self-citationGaza‐Bulseco, G., Bulseco, A., Chumsae, C. M., & Liu, H. (2007) · Journal of Chromatography B · doi:10.1016/j.jchromb.2007.12.001 · Cited by 31
Self-citationJiang, G., Yu, C., Yadav, D. B., Hu, Z., Amurao, A., Duenas, E. T., Wong, M., Iverson, M., Zheng, K., Lam, X. M., et al. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.04.027 · Cited by 31
King, C. A., Patel, R., Ponniah, G., Nowak, C., Neill, A., Gu, Z., & Liu, H. (2018) · Journal of Chromatography B · doi:10.1016/j.jchromb.2018.03.049 · Cited by 31
Self-citationMicroheterogeneity of a purified IgG1, due to asymmetric fab glycosylation
Grebenau, R. C., Goldenberg, D. M., Chien-Hsing, C., Koch, G. A., Gold, D. V., Kunz, A., & Hansen, H. J. (1992) · Molecular Immunology · doi:10.1016/0161-5890(92)90185-z · Cited by 29
Valliere‐Douglass, J. F., Brady, L. J., Farnsworth, C. W., Pace, D. L., Balland, A., Wallace, A., Wang, W., Treuheit, M. J., & Yan, B. (2008) · Glycobiology · doi:10.1093/glycob/cwn116 · Cited by 29
Characterization of Oxidative Carbonylation on Recombinant Monoclonal Antibodies
Yang, Y., Stella, C., Wang, W., Schöneich, C., & Gennaro, L. A. (2014) · Analytical Chemistry · doi:10.1021/ac4039866 · Cited by 29
Chumsae, C. M., Hossler, P., Raharimampionona, H., Zhou, Y., McDermott, S., Racicot, C., Radziejewski, C. H., & Zhou, Z. S. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b00801 · Cited by 29
Liu, H., Ren, W., Zong, L., Zhang, J., & Wang, Y. (2018) · Analytical Biochemistry · doi:10.1016/j.ab.2018.10.002 · Cited by 28
Self-citationCysteine Racemization on IgG Heavy and Light Chains
Zhang, Q., & Flynn, G. C. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.506915 · Cited by 27
Improved Solution-State Properties of Monoclonal Antibodies by Targeted Mutations
Kuhn, A. B., Kube, S., Karow‐Zwick, A. R., Seeliger, D., Garidel, P., Blech, M., & Schäfer, L. V. (2017) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.7b09126 · Cited by 27
Casaz, P., Boucher, E. N., Wollacott, R., Pierce, B. G., Rivera, R., Sedic, M., Ozturk, S. S., Thomas, W. D., & Wang, Y. (2014) · mAbs · doi:10.4161/19420862.2014.975658 · Cited by 26
Nemergut, M., Žoldák, G., Schaefer, J. V., Kast, F., Miškovský, P., Plückthun, A., & Sedlák, E. (2017) · Protein Science · doi:10.1002/pro.3278 · Cited by 26
Development of scoring functions for antibody sequence assessment and optimization
Seeliger, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076909 · Cited by 24 · cited 1×
“Various tools including in silico calculation, in vitro assays or in vivo animal models are designed to identify amino acid sequences causing immunogenicities.(81,83,84) Additional immu-”
MethodDiscovery and characterization of hydroxylysine in recombinant monoclonal antibodies
Xie, Q., Moore, B. N., & Beardsley, R. L. (2015) · mAbs · doi:10.1080/19420862.2015.1122148 · Cited by 23
Zhao, J., Saunders, J., Schussler, S. D., Rios, S. E., Insaidoo, F. K., Fridman, A. L., Li, H., & Liu, Y. (2017) · mAbs · doi:10.1080/19420862.2017.1332552 · Cited by 23
Valliere‐Douglass, J. F., Connell‐Crowley, L., Jensen, R. M., Schnier, P. D., Trilisky, E. I., Leith, M., Follstad, B. D., Kerr, J., Lewis, N. E., Vunnum, S., et al. (2010) · Protein Science · doi:10.1002/pro.495 · Cited by 22
Hofmann, M., Winzer, M., Weber, C., & Gieseler, H. (2017) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12699 · Cited by 18
Evaluation of Effects of Fc Domain High-Mannose Glycan on Antibody Stability
Lu, Y., Westland, K., Ma, Y.-H., & Gadgil, H. S. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23284 · Cited by 15
Assessment of the immunogenicity of residual host cell protein impurities of OsrHSA
Abiri, N., Pang, J., Ou, J., Shi, B., Wang, X., Zhang, S., Sun, Y., & Yang, D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193339 · Cited by 14
Nowak, C., Ponniah, G., Cheng, G. C., Kita, A., Neill, A., Kori, Y., & Liu, H. (2015) · Analytical Biochemistry · doi:10.1016/j.ab.2015.12.004 · Cited by 11
Self-citation
Cited by
Predicting antibody developability profiles through early stage discovery screening
Bailly, M., Mieczkowski, C., Juan, V., Metwally, E., Tomazela, D., Baker, J., Uchida, M., Kofman, E., Raoufi, F., Motlagh, S., et al. (2020) · mAbs · doi:10.1080/19420862.2020.1743053 · Cited by 228
Self-citationEngineered Protein Scaffolds as Next-Generation Therapeutics
Gebauer, M., & Skerra, A. (2020) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021118 · Cited by 164
Lai, P.-K., Gallegos, A., Mody, N., Sathish, H. A., & Trout, B. L. (2022) · mAbs · doi:10.1080/19420862.2022.2026208 · Cited by 103
Sawyer, W. S., Srikumar, N., Carver, J., Chu, P. Y., Shen, A., Xu, A., Williams, A. J., Spiess, C., Wu, C., Liu, Y., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1917383117 · Cited by 55
“Comparing these pools against the highperforming pools (3, 4, 7, 8) showed a decrease in overall intensity of correctly paired bispecific antibodies as well as an increase in the overall intensity of half-antibodies, which both contribute to the lower percent of correct pair matching.”
BackgroundBashour, H., Smorodina, E., Pariset, M., Zhong, J., Akbar, R., Chernigovskaya, M., Lê Quý, K., Snapkow, I., Rawat, P., Krawczyk, K., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06561-3 · Cited by 32
Metadata
- Authors
- Xu, Y., Wang, D., Mason, B., Rossomando, T., Li, N., Liu, D., Cheung, J. K., Xu, W., Raghava, S., Katiyar, A., Nowak, C., Xiang, T., Dong, D. D., Sun, J., Beck, A., & Liu, H.
- Venue
- mAbs
- Publisher
- Informa UK Limited
- Published
- 2018-12-17
- Volume
- 11
- Issue
- 2
- Pages
- 239-264
- ISSN
- 1942-0862 (ISSN-L)
- 1942-0870
- OpenAlex
- W2904971004
- Cited by
- 264
- References
- 322
- FWCI
- 7.53
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.